Stem cell hope for rare brain disease: new expanded access trial opens
NCT ID NCT07238062
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study offers expanded access to an experimental stem cell treatment for up to 7 adults with Multiple System Atrophy (MSA), a rare and serious brain disorder. Participants will receive 12 intravenous infusions and 6 spinal injections of donor stem cells over 44 weeks. The goal is to evaluate safety and whether the treatment can help control the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hope Biosciences Research Foundation
AVAILABLESugar Land, Texas, 77478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a brain disease change behavior years before diagnosis?
- Can an experimental pill slow a rare brain disease? a trial puts ATH434 to the test.
- Can a new rowing seat help veterans with paralysis row freely?
- Scientists decode gait signatures to spot brain diseases
- Can a Thigh-Worn sensor outsmart dizziness questionnaires?
- Scientists hunt for clues to diagnose Parkinson's earlier